297 related articles for article (PubMed ID: 24317792)
1. Thrombomodulin domain 1 ameliorates diabetic nephropathy in mice via anti-NF-κB/NLRP3 inflammasome-mediated inflammation, enhancement of NRF2 antioxidant activity and inhibition of apoptosis.
Yang SM; Ka SM; Wu HL; Yeh YC; Kuo CH; Hua KF; Shi GY; Hung YJ; Hsiao FC; Yang SS; Shieh YS; Lin SH; Wei CW; Lee JS; Yang CY; Chen A
Diabetologia; 2014 Feb; 57(2):424-34. PubMed ID: 24317792
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of NLRP3 inflammasome ameliorates podocyte damage by suppressing lipid accumulation in diabetic nephropathy.
Wu M; Yang Z; Zhang C; Shi Y; Han W; Song S; Mu L; Du C; Shi Y
Metabolism; 2021 May; 118():154748. PubMed ID: 33675822
[TBL] [Abstract][Full Text] [Related]
3. LincRNA-Gm4419 knockdown ameliorates NF-κB/NLRP3 inflammasome-mediated inflammation in diabetic nephropathy.
Yi H; Peng R; Zhang LY; Sun Y; Peng HM; Liu HD; Yu LJ; Li AL; Zhang YJ; Jiang WH; Zhang Z
Cell Death Dis; 2017 Feb; 8(2):e2583. PubMed ID: 28151474
[TBL] [Abstract][Full Text] [Related]
4. Protective effect of ginsenoside metabolite compound K against diabetic nephropathy by inhibiting NLRP3 inflammasome activation and NF-κB/p38 signaling pathway in high-fat diet/streptozotocin-induced diabetic mice.
Song W; Wei L; Du Y; Wang Y; Jiang S
Int Immunopharmacol; 2018 Oct; 63():227-238. PubMed ID: 30107367
[TBL] [Abstract][Full Text] [Related]
5. Novel biphenyl diester derivative AB-38b inhibits NLRP3 inflammasome through Nrf2 activation in diabetic nephropathy.
Du L; Wang J; Chen Y; Li X; Wang L; Li Y; Jin X; Gu X; Hao M; Zhu X; Yin X; Lu Q
Cell Biol Toxicol; 2020 Jun; 36(3):243-260. PubMed ID: 31768838
[TBL] [Abstract][Full Text] [Related]
6. Dimethyl fumarate-mediated Nrf2/ARE pathway activation and glibenclamide-mediated NLRP3 inflammasome cascade inhibition alleviate type II diabetes-associated fatty liver in rats by mitigating oxidative stress and inflammation.
Dwivedi DK; Jena GB
J Biochem Mol Toxicol; 2023 Jul; 37(7):e23357. PubMed ID: 36999408
[TBL] [Abstract][Full Text] [Related]
7. Sarsasapogenin alleviates diabetic nephropathy through suppression of chronic inflammation by down-regulating PAR-1: In vivo and in vitro study.
Tang ZZ; Zhang YM; Zheng T; Huang TT; Ma TF; Liu YW
Phytomedicine; 2020 Nov; 78():153314. PubMed ID: 32882582
[TBL] [Abstract][Full Text] [Related]
8. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome.
Shao A; Wu H; Hong Y; Tu S; Sun X; Wu Q; Zhao Q; Zhang J; Sheng J
Mol Neurobiol; 2016 Jul; 53(5):3462-3476. PubMed ID: 26091790
[TBL] [Abstract][Full Text] [Related]
9. Spop ameliorates diabetic nephropathy through restraining NLRP3 inflammasome.
Wang B; Dai Z; Gao Q; Liu Y; Gu G; Zheng H
Biochem Biophys Res Commun; 2022 Feb; 594():131-138. PubMed ID: 35081502
[TBL] [Abstract][Full Text] [Related]
10. Hyperuricemia-induced NLRP3 activation of macrophages contributes to the progression of diabetic nephropathy.
Kim SM; Lee SH; Kim YG; Kim SY; Seo JW; Choi YW; Kim DJ; Jeong KH; Lee TW; Ihm CG; Won KY; Moon JY
Am J Physiol Renal Physiol; 2015 May; 308(9):F993-F1003. PubMed ID: 25651569
[TBL] [Abstract][Full Text] [Related]
11. Huangkui capsule alleviates renal tubular epithelial-mesenchymal transition in diabetic nephropathy via inhibiting NLRP3 inflammasome activation and TLR4/NF-κB signaling.
Han W; Ma Q; Liu Y; Wu W; Tu Y; Huang L; Long Y; Wang W; Yee H; Wan Z; Tang R; Tang H; Wan Y
Phytomedicine; 2019 Apr; 57():203-214. PubMed ID: 30785016
[TBL] [Abstract][Full Text] [Related]
12. Punicalagin Protects Diabetic Nephropathy by Inhibiting Pyroptosis Based on TXNIP/NLRP3 Pathway.
An X; Zhang Y; Cao Y; Chen J; Qin H; Yang L
Nutrients; 2020 May; 12(5):. PubMed ID: 32456088
[TBL] [Abstract][Full Text] [Related]
13. The purinergic 2X7 receptor participates in renal inflammation and injury induced by high-fat diet: possible role of NLRP3 inflammasome activation.
Solini A; Menini S; Rossi C; Ricci C; Santini E; Blasetti Fantauzzi C; Iacobini C; Pugliese G
J Pathol; 2013 Nov; 231(3):342-53. PubMed ID: 23843215
[TBL] [Abstract][Full Text] [Related]
14. Favorable effect of rivaroxaban against vascular dysfunction in diabetic mice by inhibiting NLRP3 inflammasome activation.
Li Q; Yang XT; Wei W; Hu XP; Li XX; Xu M
J Cell Physiol; 2022 Aug; 237(8):3369-3380. PubMed ID: 35675485
[TBL] [Abstract][Full Text] [Related]
15. Stabilization of endogenous Nrf2 by minocycline protects against Nlrp3-inflammasome induced diabetic nephropathy.
Shahzad K; Bock F; Al-Dabet MM; Gadi I; Nazir S; Wang H; Kohli S; Ranjan S; Mertens PR; Nawroth PP; Isermann B
Sci Rep; 2016 Oct; 6():34228. PubMed ID: 27721446
[TBL] [Abstract][Full Text] [Related]
16. Astragaloside IV ameliorates diabetic nephropathy in
Feng H; Zhu X; Tang Y; Fu S; Kong B; Liu X
Int J Mol Med; 2021 Aug; 48(2):. PubMed ID: 34278447
[TBL] [Abstract][Full Text] [Related]
17. Kidney-targeting Smad7 gene transfer inhibits renal TGF-β/MAD homologue (SMAD) and nuclear factor κB (NF-κB) signalling pathways, and improves diabetic nephropathy in mice.
Ka SM; Yeh YC; Huang XR; Chao TK; Hung YJ; Yu CP; Lin TJ; Wu CC; Lan HY; Chen A
Diabetologia; 2012 Feb; 55(2):509-19. PubMed ID: 22086159
[TBL] [Abstract][Full Text] [Related]
18. Osthole mitigates progressive IgA nephropathy by inhibiting reactive oxygen species generation and NF-κB/NLRP3 pathway.
Hua KF; Yang SM; Kao TY; Chang JM; Chen HL; Tsai YJ; Chen A; Yang SS; Chao LK; Ka SM
PLoS One; 2013; 8(10):e77794. PubMed ID: 24204969
[TBL] [Abstract][Full Text] [Related]
19. Pioglitazone ameliorates glomerular NLRP3 inflammasome activation in apolipoprotein E knockout mice with diabetes mellitus.
Wang Y; Yu B; Wang L; Yang M; Xia Z; Wei W; Zhang F; Yuan X
PLoS One; 2017; 12(7):e0181248. PubMed ID: 28708885
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-10 negatively regulates inflammation in diabetic kidney via targeting activation of the NLRP3 inflammasome.
Ding H; Li J; Li Y; Yang M; Nie S; Zhou M; Zhou Z; Yang X; Liu Y; Hou FF
Mol Ther; 2021 Jul; 29(7):2308-2320. PubMed ID: 33744467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
